Recombinant mutant thrombin receptor and related pharmaceuticals

Details Recombinant mutant thrombin receptor and related pharmaceuticals Recombinant mutant thrombin receptor and related pharmaceuticals

1995-06-07

1998-08-25

Wax, Robert A.

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Hydrolase

4352523, 4353201, 536 232, C12N 974, C12N 120, C07H 2104

Patent

active

057982481

ABSTRACT:
Proteolytically inactive thrombin mutated at positions 43 and/or 99 and/or 205, whereby said mutation renders thrombin an antagonist of thrombin receptor.

REFERENCES:
patent: 4783330 (1988-11-01), Furie
patent: 4859609 (1989-08-01), Dull et al.
patent: 5256766 (1993-10-01), Coughlin
Baniyash et al., J. Biol. Chem., vol. 264, pp. 13252-13257 (1989).
Bar-Shavit et al., Journal of Cell Biology, vol. 112(2), pp. 335-344 (1991).
Berndt et al., Elsevier/North Holland Biomedical Press, pp. 43-74, "Platelets in Biology and Pathology" (1981).
Bode et al., EMBO Journal, vol. 8, pp. 3467-3475 (1989).
Edington, Biotechnology, vol. 10, pp. 383-389 (1992).
Foster et al., id., vol. 82, pp. 4673-4677 (1985).
Frost et al., J. Cell. Biol., vol. 105, pp. 2551-2558 (1987).
Gearing et al., EMBO Journal, vol. 8, pp. 3667-3676 (1989).
Greco et al., Blood, vol. 75, pp. 1983-1990 (1990).
Gronke et al., J. Biol. Chem., vol. 262, pp. 3030-3036 (1987).
Hui et al., BBRC, vol. 184, pp. 790-796 (1992).
Jackman et al., Proc. Natl. Acad. Sci., vol. 84, pp. 6425-6429 (1987).
Martin et al., Biochem., vol. 14, pp. 1308-1314 (1975).
Masu et al., Nature, vol. 329, pp. 836-838 (1987).
Okamura et al., J. Biol. Chem., vol. 253, pp. 3435-3443 (1978).
Phillips, Thrombin Diath. Haemorrh., vol. 32, pp. 207-215 (1974).
Pipili-Synetos et al., Biochem. Biophys. Res. Comm., vol. 171, pp. 913-919 (1990).
Tollefsen et al., J. Biol. Chem., vol. 249, pp. 2646-2651 (1974).
Rasmussen et al., FEBS Letters, vol. 288, pp. 123-128 (1991).
Ruda et al., Biochemical Pharmacology, vol. 39(2), pp. 373-381 (1990).
Ruda et al., Annals. New York Academy of Sciences, vol. 485, pp. 439-442 (1986).
Ruda et al., Biochemical Pharmacology, vol. 37(12), pp. 2417-2426 (1988).
Sambrook et al., Molecular Cloning, 2nd edition, Cold Spring Harbor (NY) Press, Ch. 12.
Sambrook et al., op. cit., 11.2-11.8.
Scarborough et al., J. Biol. Chem., vol. 267, pp. 13146-13149 (1992).
Seed et al., id., vol. 84, pp. 3365-3369 (1987).
Sevier, Clin. Chem., vol. 27, pp. 1797-1806 (1981).
Suzuki, Acta Haematol., vol. 51, pp. 1655-1664 (1988).
Van Obberghen-Schilling et al., FEBS Letters, vol. 262, pp. 330-334 (1990).
Vu et al., Nature, vol. 353, pp. 674-677 (1991).
Vu et al., Cell, vol. 64, pp. 1057-1068 (1991).
Walz et al., Annals. New York Academy of Sciences, vol. 485, pp. 323-334 (1986).
Watson et al., Recombinant DNA, 2nd ed., New York, Scientific American, p. 108.
Workman et al., J. Biol. Chem., vol. 252, pp. 7118-7123 (1977).
Young et al., Proc. Natl. Acad. Sci. USA, vol. 80, pp. 1194-1198 (1983).
Degen et al. (1987) Biochemistry 26, 6165-6177.
Power et al. (1989) Biotechnology, Rehm & Reed, eds., vol. 7b, Gene Technology, 262-276.

Affiliated with

Also associated with

Rating

Recombinant mutant thrombin receptor and related pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant mutant thrombin receptor and related pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant mutant thrombin receptor and related pharmaceuticals will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-35656